Edit |   |
---|---|
Product Name | AGI-5198 |
Description | AGI-5198 is a small molecule which can act as a R132 mutant isocitrate dehydrogenase inhibitor. It is provided as a powder. This product acts on the following target types: Dehydrogenase (GAPDH, GPDH, IMPDH, PHGDH, LDH, DHODH, ALDH, GDH, IDH, UGDH, DPD, DHPDH, and MDH). This product acts on the following biochemical pathways: Mitochondrial function, NADH. This product may be of interest in the following research areas and diseases: Cancer. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 462.56 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | AGI-5198, N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide, 1355326-35-0 |
Gene, Accession, CAS # | CAS: 1355326-35-0 |
Catalog # | abx283066 |
Price | please inquire |
Order / More Info | AGI-5198 from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950